Over the past two decades, altered SOX9 expression has been studied in various cancers—including colorectal, lung, laryngeal, esophageal, hepatocellular, and breast cancers—and has been associated with advanced TNM stages, higher tumor grades, lymphovascular invasion, and distant metastases [13]. Here, SOX9 is linked to neoplasm.